Actualités IR BioSciences Holdings Inc New (CE) - IRBS | Actions OTCMarkets

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

- Annual Report (10-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K x Annual...

- Notification that Quarterly Report will be submitted late (NT 10-Q)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE...

- Notification that Annual Report will be submitted late (NT 10-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING...

- Current report filing (8-K)

UN ITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT...

- Quarterly Report (10-Q)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to...

- Notification that Quarterly Report will be submitted late (NT 10-Q)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE...

ImmuneRegen BioSciences(R) Reports Positive Results in Cancer Vaccine Studies in Radboud University Collaboration

SCOTTSDALE, Ariz., Oct. 28, 2010 (GLOBE NEWSWIRE) -- ImmuneRegen BioSciences, Inc.®, a wholly owned subsidiary of IR BioSciences Holdings, Inc...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT...

ImmuneRegen BioSciences(R) Reports Scancell Collaboration Yielding Positive Results in Cancer Vaccine Studies of Homspera(R)

SCOTTSDALE, Ariz., Sept. 8, 2010 (GLOBE NEWSWIRE) -- ImmuneRegen BioSciences, Inc.®, a wholly owned subsidiary of IR BioSciences Holdings, Inc...

ImmuneRegen BioSciences(R) Invited to Submit Full Proposal to BARDA for Homspera(R) as a Potential Medical Countermeasure for In

SCOTTSDALE, Ariz., Aug. 31, 2010 (GLOBE NEWSWIRE) -- ImmuneRegen BioSciences®, a wholly owned subsidiary of IR Biosciences Holdings Inc...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

IR BioSciences Holdings Inc New (CE) (IRBS)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

IRBS Actualités

- Annual Report (10-K)

- Notification that Quarterly Report will be submitted late (NT 10-Q)

- Notification that Annual Report will be submitted late (NT 10-K)

- Current report filing (8-K)

- Quarterly Report (10-Q)

- Notification that Quarterly Report will be submitted late (NT 10-Q)

ImmuneRegen BioSciences(R) Reports Positive Results in Cancer Vaccine Studies in Radboud University Collaboration

- Current report filing (8-K)

ImmuneRegen BioSciences(R) Reports Scancell Collaboration Yielding Positive Results in Cancer Vaccine Studies of Homspera(R)

ImmuneRegen BioSciences(R) Invited to Submit Full Proposal to BARDA for Homspera(R) as a Potential Medical Countermeasure for In

University of Rochester Medical Center Receives $15 Million in Government Funding to Research ImmuneRegen's Homspera(R)

- Quarterly Report (10-Q)

- Notification that Quarterly Report will be submitted late (NT 10-Q)

- Current report filing (8-K)

- Quarterly Report (10-Q)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

IR BioSciences Holdings Inc New (CE) (IRBS) Actualités

IR BioSciences Holdings Inc New (CE) (IRBS)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

IRBS Actualités

- Annual Report (10-K)

- Notification that Quarterly Report will be submitted late (NT 10-Q)

- Notification that Annual Report will be submitted late (NT 10-K)

- Current report filing (8-K)

- Quarterly Report (10-Q)

- Notification that Quarterly Report will be submitted late (NT 10-Q)

ImmuneRegen BioSciences(R) Reports Positive Results in Cancer Vaccine Studies in Radboud University Collaboration

- Current report filing (8-K)

ImmuneRegen BioSciences(R) Reports Scancell Collaboration Yielding Positive Results in Cancer Vaccine Studies of Homspera(R)

ImmuneRegen BioSciences(R) Invited to Submit Full Proposal to BARDA for Homspera(R) as a Potential Medical Countermeasure for In

University of Rochester Medical Center Receives $15 Million in Government Funding to Research ImmuneRegen's Homspera(R)

- Quarterly Report (10-Q)

- Notification that Quarterly Report will be submitted late (NT 10-Q)

- Current report filing (8-K)

- Quarterly Report (10-Q)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités